All In Biotech

Drug Trial Radar · NCT00977938

The Dual Antiplatelet Therapy Study (DAPT Study)

A Prospective, Multi-center, Randomized, Double-blind Trial to Assess the Effectiveness and Safety of 12 Versus 30 Months of Dual Antiplatelet Therapy in Subjects Undergoing Percutaneous Coronary Intervention With Either Drug-eluting Stent or Bare Metal Stent Placement for the Treatment of Coronary Artery Lesions

Last checked: Nov 19, 2026Latest source record: Jun 9, 2017 (this record)Source: ClinicalTrials.govMethods & limitations

CompletedResults posted on the registryPivotal-lookingRandomized with 25,682 participants. This is a heuristic, not a regulatory label.

Status

Completed

Enrollment

25,682

Actual

Start

Oct 2009

Primary completion

Jun 2014

Study completion Jun 2014

Sponsor

Lead sponsor
Baim Institute for Clinical ResearchAcademic, hospital or other
Sponsor type
Academic, hospital or other
Collaborators
Abbott; Boston Scientific Corporation; Bristol-Myers Squibb; Sanofi-Synthelabo; Cordis US Corp.; Eli Lilly and Company; Daiichi Sankyo; Medtronic
First posted
Sep 16, 2009

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Phase 4
Allocation
Randomized
Model
Parallel
Masking
Triple (participant, care provider, investigator)
Primary purpose
Treatment
Who can join
All sexes, from 18 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

The DAPT Study is a double blind randomized controlled trial intended to determine the appropriate duration for dual antiplatelet therapy (the combination of aspirin and a second anti-clotting medication) as well as the safety and effectiveness of dual antiplatelet therapy to protect patients from stent thrombosis and major adverse cardiovascular and cerebrovascular events (MACCE) following the implantation of drug-eluting coronary stents. Similar analysis will be conducted in a smaller cohort of bare metal coronary stent - treated subjects.

Conditions

  • Coronary Artery Disease

Interventions

  • Placebo & AspirinDrug

  • Clopidogrel & Aspirin, Prasugrel & AspirinDrug

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. MACCE (Death, Myocardial Infarction or Stroke) - Randomized DES ITTTime frame: 18 months (12-30 months post-index procedure)
  2. Definite or Probable Stent Thrombosis (ST) - Randomized DES ITTTime frame: 18 months (12-30 months post-index procedure)
  3. GUSTO Severe or Moderate Bleeding - Randomized DES ITTTime frame: 18 months (12-30 months post-index procedure)

Locations

256 sites in 10 countries. Site status is shown where the registry gives one.

  • Thomas Hospital

    Fairhope, Alabama

  • Mercy Gilbert Medical Center

    Gilbert, Arizona

  • Heart & Vascular Center of Arizona

    Phoenix, Arizona

  • Scottsdale Health Care

    Scottsdale, Arizona

  • NEA Baptist Clinic

    Jonesboro, Arkansas

  • University of Arkansas (Central VA) for Medical Science

    Little Rock, Arkansas

  • Arkansas Heart Hospital

    Little Rock, Arkansas

  • California Cardiovascular Consultants/ Washington Hospital

    Fremont, California

  • The Foundation for Cardiovascular Medicine

    La Jolla, California

  • Mercy General Hospital

    Sacramento, California

  • UC San Diego Medical Center

    San Diego, California

  • California Pacific Medical Center

    San Francisco, California

  • St. Joseph's Medical Center- CA

    Stockton, California

  • Torrance Memorial Medical Center / Vasek Polak Research Program

    Torrance, California

  • Harbor - UCLA Medical Center

    Torrance, California

  • Medical Center of Aurora

    Aurora, Colorado

  • Connecticut Clinical Research, LLC

    Bridgeport, Connecticut

  • Bridgeport Hospital

    Bridgeport, Connecticut

  • St. Vincent's Medical Center

    Stamford, Connecticut

  • Washington Hospital Center

    Washington D.C., District of Columbia

  • Palm Beach Heart Research Institute

    Atlantis, Florida

  • Bay Area Cardiology Associates/ Brandon Regional Hospital

    Brandon, Florida

  • Jacksonville Heart Center

    Jacksonville, Florida

  • Watson Clinic Center for Research

    Lakeland, Florida

  • Diagnostic Cardiology Associates

    Lauderdale Lakes, Florida

  • Melbourne Internal Medicine Assoc

    Melbourne, Florida

  • Baptist Hospital of Miami

    Miami, Florida

  • Munroe Regional Medical Center

    Ocala, Florida

  • Ocala Regional Medical Center

    Ocala, Florida

  • Florida Hospital

    Orlando, Florida

  • Baptist Hospital

    Pensacola, Florida

  • Sacred Heart Hospital

    Pensacola, Florida

  • Tallahassee Memorial Hospital

    Tallahassee, Florida

  • Pepin Heart Hospital

    Tampa, Florida

  • Winter Haven Hospital

    Winter Haven, Florida

  • Emory University Hospital Midtown

    Atlanta, Georgia

  • Piedmont Hospital Research Institute

    Atlanta, Georgia

  • Emory University Hospital

    Atlanta, Georgia

  • Medical Center Central Georgia

    Macon, Georgia

  • Redmond Regional Hospital

    Rome, Georgia

Showing 40 of 256 sites, US sites first. The full list is on the registry record.

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.